Therefore, the present study’s strength is limited to exploring the role of APOL1 dynamics in the modulation of the RAS in kidneys, but a cause-and-effect relationship of the RAS in APOL1-mediated FSGS has yet to be established. The gene discussed is APOL1; the disease is focal segmental glomerulosclerosis.